These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27303907)

  • 1. BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
    Ewald IP; Cossio SL; Palmero EI; Pinheiro M; Nascimento IL; Machado TM; Sandes KA; Toralles B; Garicochea B; Izetti P; Pereira ML; Bock H; Vargas FR; Moreira MÂ; Peixoto A; Teixeira MR; Ashton-Prolla P
    Genet Mol Biol; 2016; 39(2):223-31. PubMed ID: 27303907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
    Riahi A; Chabouni-Bouhamed H; Kharrat M
    Cancer Genet; 2017 Jan; 210():22-27. PubMed ID: 28212807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
    Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
    Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic rearrangements in BRCA1 and BRCA2: A literature review.
    Ewald IP; Ribeiro PL; Palmero EI; Cossio SL; Giugliani R; Ashton-Prolla P
    Genet Mol Biol; 2009 Jul; 32(3):437-46. PubMed ID: 21637503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome.
    Vicente R; Alpuim Costa D; Vitorino M; Mendes AD; Santos C; Fontes-Sousa M
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME
    Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.
    Ewald IP; Izetti P; Vargas FR; Moreira MA; Moreira AS; Moreira-Filho CA; Cunha DR; Hamaguchi S; Camey SA; Schmidt A; Caleffi M; Koehler-Santos P; Giugliani R; Ashton-Prolla P
    Hered Cancer Clin Pract; 2011 Dec; 9(1):12. PubMed ID: 22185575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series.
    McVeigh TP; Cody N; Carroll C; Duff M; Farrell M; Bradley L; Gallagher D; McDevitt T; Green AJ
    Cancer Genet; 2017 Aug; 214-215():1-8. PubMed ID: 28595730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
    Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ
    BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
    Andaluz S; Zhao B; Sinha S; Lagniton PNP; Costa DA; Ding X; Brito M; Wang SM
    BMC Genomics; 2024 Apr; 25(1):416. PubMed ID: 38671360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families.
    Moisan AM; Fortin J; Dumont M; Samson C; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; Provencher L; Voyer P; Goldgar D; Bridge P; Simard J
    Genet Test; 2006; 10(2):104-15. PubMed ID: 16792513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry.
    Peixoto A; Santos C; Pinto P; Pinheiro M; Rocha P; Pinto C; Bizarro S; Veiga I; Principe AS; Maia S; Castro F; Couto R; Gouveia A; Teixeira MR
    Clin Genet; 2015 Jul; 88(1):41-8. PubMed ID: 24916970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
    Casey MJ; Bewtra C
    Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario.
    de Freitas Ribeiro AA; Junior NMC; Dos Santos LL
    Eur J Med Res; 2024 Mar; 29(1):187. PubMed ID: 38504328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer.
    Gutiérrez-Enríquez S; de la Hoya M; Martínez-Bouzas C; Sanchez de Abajo A; Ramón y Cajal T; Llort G; Blanco I; Beristain E; Díaz-Rubio E; Alonso C; Tejada MI; Caldés T; Diez O
    Breast Cancer Res Treat; 2007 May; 103(1):103-7. PubMed ID: 17063271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.
    Vasickova P; Machackova E; Lukesova M; Damborsky J; Horky O; Pavlu H; Kuklova J; Kosinova V; Navratilova M; Foretova L
    BMC Med Genet; 2007 Jun; 8():32. PubMed ID: 17561994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.